EMJ Podcast: Insights For Healthcare Professionals

This podcast is a discussion around the impact of COVID-19 on healthcare systems and patient care backlogs. Hosting the episode is Professor Gregory Lip, Price-Evans Chair, Cardiovascular Medicine, University of Liverpool, who is joined by Professor Fausto Pinto, Dean of the Faculty of Medicine,  University of Lisbon. Tune in to find out the impact of COVID-19 on healthcare systems overall, but particularly on the diagnosis of arrythmia and dyslipidemia. This podcast has been sponsored Daiichi Sankyo.  

CVD/22/0045 - March 2022  

This podcast is an exploration of the impact of COVID-19 on the diagnosis and treatment of cardiovascular patients. Hosting is Professor Gregory Lip, Price-Evans Chair, Cardiovascular Medicine, University of Liverpool, who is joined by Professor Jose Luis Zamorano, Professor of Medicine and Head of Cardiology, Hospital Ramón y Cajal. Tune in to find out about the consequences of COVID-19 for cardiovascular patients, particularly those with arrythmia and dyslipidaemia. This podcast has been sponsored by Daiichi Sankyo.   

CVD/22/0044 - March 2022  

This podcast has been funded by a Pfizer educational grant, in which the position and discussions might not represent the position of Pfizer.

This week, Jonathan contemplates the practice of mindfulness, from its ancient Vedic roots to its contemporary popularity, and how applying this focused thinking can improve our wellbeing. Through exploring the methodology of this spiritual exercise, detailing statistics from clinical trials, and examining real-world applications, we determine the ways in which patience can benefit patients.

This week, Jonathan broaches a controversial topic: Do vitamins and supplements actually improve our health, or are they a waste of our money? From Vitamin A to Vitamin Z, Dr Sackier explores the perceived health benefits of supplements, why our modern diet has transcended deficiency diseases, and how improving the evidence provided by regulatory bodies could help to justify the billions of dollars that half of all Americans spend on these substances.

This week, Jonathan is joined by Mike Einziger, a multiple Grammy-nominated musician, inventor, and technology entrepreneur. They speak about Mike’s impressive career in music and interesting gravitation towards science, touching on the technology companies he has founded: Mixhalo and Versicolor Technologies. Conversations also cover the skin condition tinea versicolor, pigmentation, and other applications of Mike’s curious involvement in dermatology.  

This podcast is supported by Janssen Pharmaceutical Companies of Johnson & Johnson. The views expressed in this podcast are those of the individual speaker and do not necessarily reflect the views of Janssen Pharmaceutical Companies of Johnson & Johnson.

The novel data presented at EULAR 2021 highlights the latest treatment options and safety aspects for patients with psoriatic arthritis (PsA). Discussing the data presented by Laura Coates at EULAR 2021, the episode centres on the safety and efficacy of guselkumab treatment for patients with PsA who inadequately respond to TNF inhibitors. Other key research presented at EULAR 2021 is spotlighted, including clinical trials investigating alternative PsA treatment options such as selective allosteric TYK2 inhibitor deucravacitinib, an analysis of IL-17 inhibitor secukinumab and new insights into faecal microbiota transplantation.

This podcast is supported by Janssen Pharmaceutical Companies of Johnson & Johnson. The views expressed in this podcast are those of the individual speaker and do not necessarily reflect the views of Janssen Pharmaceutical Companies of Johnson & Johnson.

This week, Jonathan is joined by Dr Steve Wexner, Chairman of the Department of Colorectal Surgery at the Cleveland Clinic, Miami, Florida, USA. In this episode, the pair consider how the coronavirus pandemic has affected surgery, faculty meetings, and clinical education. As they outline Dr Wexner’s illustrious career, a range of pertinent topics are discussed, including ‘greener’ travel and remote healthcare, disparities in access to modern medicine and the poverty gap, the legal steps involved with safely innovating in science, and advances in minimally invasive surgery.